Mifepristone's Role in Treating Uterine Fibroids

The Hidden Costs of Abortion Politics

From an early age, Deja Cradle knew something was wrong. At 11, her periods were not the occasional cramps. Instead, Deja's were "horrible." She often stayed home or left school because nausea and pain were so intense that she'd vomit. Her mother said to brush it off. And she did. For nearly 20 years. Doing what was normal for many women in Springfield, Massachusetts, she suffered in silence. This is a story about uptight politics and untreated women.

The Abortion Drug That U.S. Politics Have Sidelined

Mifepristone, an approved medication for abortion, can also help uterine fibroids and endometriosis. A non-invasive option, this drug can shrink fibroids up to 50% and reduce bleeding and pain from endometriosis. But mifepristone faces more red tape here than elsewhere. In the U.S., it's embroiled in a political tug-of-war that's leaving American women behind. A battle 90 miles away has created a situation some describe as a "hostage crisis."

Three Drug Hurdles U.S. Patients Face

Navigating a bureaucratic minefield

The U.S. has stepped up its scrutiny of mifepristone. In 2022, Louisiana made it a controlled substance. The Trump administration reviewed its safety under FDA regulations. Lawsuits in Louisiana, Texas, and Florida are pushing for more restrictions. The U.S. is restricting access to the drug and discouraging its use as a treatment option. Such obstacles leave doctors and patients searching for solutions. Some resort to Googling studies or medicine sites that prescribe it in restricted countries.

Doctors' resistance to non-standard treatment

Reactions can be swift and negative when a patient suggests, "I’ve found a study on the drug you’re dismissing." Danielle Shoback mentioned a China-based clinical trial to several doctors. They shot down her idea. But Daniel Shoback couldn't bear the pain. So she took Mifepristone on her own for two years.

The chilling effects of politics on research

The red tape and political jargon make it tough for doctors to consider mifepristone. Dr. Abby Liberty is an OB-GYN and researcher at Oregon Health and Science University. "These are (drugs) which have been shown to help women with fibroids." She sees the politics as a barrier to progress. Meanwhile, the rest of the world is moving ahead. Both drugs shrink uterine fibroids by up to 50%. So physicians in China and India are already prescribing these to patients with fibroids and endometriosis. Shrinking fibroids means shorter operating times, easier surgeries, and quicker recovery. Time in the operating room matters.

Practical Solutions for the Women Left Behind

Medical professionals already have other options. But independent research can help women seeking treatment for fibroids and endometriosis. There's no need to suffer in silence:

• Educate Yourself: Look online for clinical trials and research studies.
• Talk to Your Doctor: If your doctor is unwilling to consider certain treatments or hear you out, keep searching for someone who will.
• Seek Second Opinions: If one physician dismisses your concerns, another might be more open to exploring different options.

Not Silence, Not Stigma, but Action

Uterine fibroids are a common but serious condition. They leave you curled up on the bathroom floor. At this point, there are no easy fixes. Progress in women's health will come from awareness — and organizing.